| Lori Zelesnik, | |
|
143 Turkmar Dr, Aliquippa, PA 15001-1470 | |
| (724) 775-5325 | |
| Not Available |
| Full Name | Lori Zelesnik |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 143 Turkmar Dr, Aliquippa, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043656994 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP440261 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lori Zelesnik, 143 Turkmar Dr, Aliquippa, PA 15001-1470 Ph: () - | Lori Zelesnik, 143 Turkmar Dr, Aliquippa, PA 15001-1470 Ph: (724) 775-5325 |
News Archive
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.
The Los Angeles Times: Although healthcare has been one of the most reliable "generators of new jobs in California," the situation is changing. A "lousy economy has caught up with an industry once considered virtually immune to downturns. The sector, which employs about 1 in 10 Californians, has stalled at a time when healthcare employment continues to grow nationally.
The Florida Society of Pain Management Providers commends the Florida Board of Medicine and the Florida Board of Osteopathic Medicine in their issuances of Pain Clinic regulations / Standards of Care.
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.
› Verified 6 days ago
Mrs. Antoniette Barbuto, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2665 Brodhead Rd, Suite B, Aliquippa, PA 15001 Phone: 724-375-1230 | |
Adam Andrew, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Aliquippa, PA 15001 Phone: 180-085-0339 | |
Mrs. Heather Walsh, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2665 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-4141 | |
Mr. Gino S. Cordisco, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Aliquippa, PA 15001 Phone: 724-816-2512 Fax: 724-776-7237 | |
Douglas Kaleugher, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Aliquippa, PA 15001 Phone: 724-378-5325 Fax: 724-378-5312 | |
James Conrad Burke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Sheffield Rd, Suite B, Aliquippa, PA 15001 Phone: 724-375-1672 |